Egyptian health tech Almouneer raises $3.6M to scale its platform for treating diabetes and obesity
Summary
Almouneer has disclosed that the funds raised will be primarily allocated to support the development and expansion of DRU, which it characterizes as the first patient-centric, digitally-enabled lifestyle and diabetes management platform in the Middle East and Africa. The platform plays a critical role in diabetes, prediabetes and obesity prevention and management by connecting patients with doctors and an extensive network of healthcare providers through its app.Co-founder and CEO Noha Khater shared with TechCrunch that the seed investment will assist in attracting top talent to join Almouneer. The health tech also reported a doubling of its business volumes and revenue numbers within the past year, according to Khater.In 2017, Khater launched Almouneer as a cluster of tech-enabled clinics with a strong emphasis on ophthalmology. In this capacity, Almouneer deploys comprehensive practice management software, encompassing financial, electronic medical records and booking systems that are all interconnected.This change also coincided with the launch of its patient-centric app, DRU. The marketplace will connect patients with essential consumables such as glucose monitors, blood sugar strips, care products for their extremities and nutrition plans.Meanwhile, the seed investment will be instrumental in driving the adoption of the recently launched DRU app.